The central vein sign as a clinical diagnostic biomarker for multiple sclerosis. The central vein sign as a clinical diagnostic biomarker for multiple sclerosis. Nature reviews. Neurology Lemprière S. PMID: 31485025 Nat Rev Neurol. 2019 Oct;15(10):558. doi: 10.1038/s41582-019-0261-6. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Lemprière S. The central vein sign as a clinical diagnostic biomarker for multiple sclerosis. Nat Rev Neurol. 2019;15(10):558doi: 10.1038/s41582-019-0261-6. APA Lemprière, S. (2019). The central vein sign as a clinical diagnostic biomarker for multiple sclerosis. Nature reviews. Neurology, 15(10), 558. https://doi.org/10.1038/s41582-019-0261-6 MLA Lemprière, Sarah. "The central vein sign as a clinical diagnostic biomarker for multiple sclerosis." Nature reviews. Neurology vol. 15,10 (2019): 558. doi: https://doi.org/10.1038/s41582-019-0261-6 NLM Lemprière S. The central vein sign as a clinical diagnostic biomarker for multiple sclerosis. Nat Rev Neurol. 2019 Oct;15(10):558. doi: 10.1038/s41582-019-0261-6. PMID: 31485025. Copy Download .nbib Format: NLM AMA APA MLA NLM
Drug repurposing shows promise for Charcot-Marie-Tooth disease. Drug repurposing shows promise for Charcot-Marie-Tooth disease. Nature reviews. Neurology Lemprière S. PMID: 34373635 Nat Rev Neurol. 2021 Sep;17(9):525. doi: 10.1038/s41582-021-00550-4. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Lemprière S. Drug repurposing shows promise for Charcot-Marie-Tooth disease. Nat Rev Neurol. 2021;17(9):525doi: 10.1038/s41582-021-00550-4. APA Lemprière, S. (2021). Drug repurposing shows promise for Charcot-Marie-Tooth disease. Nature reviews. Neurology, 17(9), 525. https://doi.org/10.1038/s41582-021-00550-4 MLA Lemprière, Sarah. "Drug repurposing shows promise for Charcot-Marie-Tooth disease." Nature reviews. Neurology vol. 17,9 (2021): 525. doi: https://doi.org/10.1038/s41582-021-00550-4 NLM Lemprière S. Drug repurposing shows promise for Charcot-Marie-Tooth disease. Nat Rev Neurol. 2021 Sep;17(9):525. doi: 10.1038/s41582-021-00550-4. PMID: 34373635. Copy Download .nbib Format: NLM AMA APA MLA NLM
White matter transcriptome altered in CTE. White matter transcriptome altered in CTE. Nature reviews. Neurology Lemprière S. PMID: 34083768 Nat Rev Neurol. 2021 Jul;17(7):394. doi: 10.1038/s41582-021-00523-7. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Lemprière S. White matter transcriptome altered in CTE. Nat Rev Neurol. 2021;17(7):394doi: 10.1038/s41582-021-00523-7. APA Lemprière, S. (2021). White matter transcriptome altered in CTE. Nature reviews. Neurology, 17(7), 394. https://doi.org/10.1038/s41582-021-00523-7 MLA Lemprière, Sarah. "White matter transcriptome altered in CTE." Nature reviews. Neurology vol. 17,7 (2021): 394. doi: https://doi.org/10.1038/s41582-021-00523-7 NLM Lemprière S. White matter transcriptome altered in CTE. Nat Rev Neurol. 2021 Jul;17(7):394. doi: 10.1038/s41582-021-00523-7. PMID: 34083768. Copy Download .nbib Format: NLM AMA APA MLA NLM
APOE4 provokes tau aggregation via inhibition of noradrenaline transport. APOE4 provokes tau aggregation via inhibition of noradrenaline transport. Nature reviews. Neurology Lemprière S. PMID: 33990796 Nat Rev Neurol. 2021 Jun;17(6):328. doi: 10.1038/s41582-021-00511-x. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Lemprière S. APOE4 provokes tau aggregation via inhibition of noradrenaline transport. Nat Rev Neurol. 2021;17(6):328doi: 10.1038/s41582-021-00511-x. APA Lemprière, S. (2021). APOE4 provokes tau aggregation via inhibition of noradrenaline transport. Nature reviews. Neurology, 17(6), 328. https://doi.org/10.1038/s41582-021-00511-x MLA Lemprière, Sarah. "APOE4 provokes tau aggregation via inhibition of noradrenaline transport." Nature reviews. Neurology vol. 17,6 (2021): 328. doi: https://doi.org/10.1038/s41582-021-00511-x NLM Lemprière S. APOE4 provokes tau aggregation via inhibition of noradrenaline transport. Nat Rev Neurol. 2021 Jun;17(6):328. doi: 10.1038/s41582-021-00511-x. PMID: 33990796. Copy Download .nbib Format: NLM AMA APA MLA NLM
Hourly risk score could alert clinicians to delayed cerebral ischaemia. Hourly risk score could alert clinicians to delayed cerebral ischaemia. Nature reviews. Neurology Lemprière S. PMID: 33750930 Nat Rev Neurol. 2021 Apr;17(4):194. doi: 10.1038/s41582-021-00481-0. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Lemprière S. Hourly risk score could alert clinicians to delayed cerebral ischaemia. Nat Rev Neurol. 2021;17(4):194doi: 10.1038/s41582-021-00481-0. APA Lemprière, S. (2021). Hourly risk score could alert clinicians to delayed cerebral ischaemia. Nature reviews. Neurology, 17(4), 194. https://doi.org/10.1038/s41582-021-00481-0 MLA Lemprière, Sarah. "Hourly risk score could alert clinicians to delayed cerebral ischaemia." Nature reviews. Neurology vol. 17,4 (2021): 194. doi: https://doi.org/10.1038/s41582-021-00481-0 NLM Lemprière S. Hourly risk score could alert clinicians to delayed cerebral ischaemia. Nat Rev Neurol. 2021 Apr;17(4):194. doi: 10.1038/s41582-021-00481-0. PMID: 33750930. Copy Download .nbib Format: NLM AMA APA MLA NLM
Markers of vulnerable neurons identified in Alzheimer disease. Markers of vulnerable neurons identified in Alzheimer disease. Nature reviews. Neurology Lemprière S. PMID: 33504978 Nat Rev Neurol. 2021 Mar;17(3):132. doi: 10.1038/s41582-021-00462-3. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Lemprière S. Markers of vulnerable neurons identified in Alzheimer disease. Nat Rev Neurol. 2021;17(3):132doi: 10.1038/s41582-021-00462-3. APA Lemprière, S. (2021). Markers of vulnerable neurons identified in Alzheimer disease. Nature reviews. Neurology, 17(3), 132. https://doi.org/10.1038/s41582-021-00462-3 MLA Lemprière, Sarah. "Markers of vulnerable neurons identified in Alzheimer disease." Nature reviews. Neurology vol. 17,3 (2021): 132. doi: https://doi.org/10.1038/s41582-021-00462-3 NLM Lemprière S. Markers of vulnerable neurons identified in Alzheimer disease. Nat Rev Neurol. 2021 Mar;17(3):132. doi: 10.1038/s41582-021-00462-3. PMID: 33504978. Copy Download .nbib Format: NLM AMA APA MLA NLM
Highlights from the first virtual AAIC. Highlights from the first virtual AAIC. Nature reviews. Neurology Lemprière S. PMID: 32887959 Nat Rev Neurol. 2020 Oct;16(10):522. doi: 10.1038/s41582-020-0408-5. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Lemprière S. Highlights from the first virtual AAIC. Nat Rev Neurol. 2020;16(10):522doi: 10.1038/s41582-020-0408-5. APA Lemprière, S. (2020). Highlights from the first virtual AAIC. Nature reviews. Neurology, 16(10), 522. https://doi.org/10.1038/s41582-020-0408-5 MLA Lemprière, Sarah. "Highlights from the first virtual AAIC." Nature reviews. Neurology vol. 16,10 (2020): 522. doi: https://doi.org/10.1038/s41582-020-0408-5 NLM Lemprière S. Highlights from the first virtual AAIC. Nat Rev Neurol. 2020 Oct;16(10):522. doi: 10.1038/s41582-020-0408-5. PMID: 32887959. Copy Download .nbib Format: NLM AMA APA MLA NLM
SARS-CoV-2 detected in olfactory neurons. SARS-CoV-2 detected in olfactory neurons. Nature reviews. Neurology Lemprière S. PMID: 33398125 Nat Rev Neurol. 2021 Feb;17(2):63. doi: 10.1038/s41582-020-00449-6. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Lemprière S. SARS-CoV-2 detected in olfactory neurons. Nat Rev Neurol. 2021;17(2):63doi: 10.1038/s41582-020-00449-6. APA Lemprière, S. (2021). SARS-CoV-2 detected in olfactory neurons. Nature reviews. Neurology, 17(2), 63. https://doi.org/10.1038/s41582-020-00449-6 MLA Lemprière, Sarah. "SARS-CoV-2 detected in olfactory neurons." Nature reviews. Neurology vol. 17,2 (2021): 63. doi: https://doi.org/10.1038/s41582-020-00449-6 NLM Lemprière S. SARS-CoV-2 detected in olfactory neurons. Nat Rev Neurol. 2021 Feb;17(2):63. doi: 10.1038/s41582-020-00449-6. PMID: 33398125; PMCID: PMC7781190. Copy Download .nbib Format: NLM AMA APA MLA NLM
A brain implant decodes speech. A brain implant decodes speech. Nature reviews. Neurology Lemprière S. PMID: 34373632 Nat Rev Neurol. 2021 Sep;17(9):525. doi: 10.1038/s41582-021-00552-2. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Lemprière S. A brain implant decodes speech. Nat Rev Neurol. 2021;17(9):525doi: 10.1038/s41582-021-00552-2. APA Lemprière, S. (2021). A brain implant decodes speech. Nature reviews. Neurology, 17(9), 525. https://doi.org/10.1038/s41582-021-00552-2 MLA Lemprière, Sarah. "A brain implant decodes speech." Nature reviews. Neurology vol. 17,9 (2021): 525. doi: https://doi.org/10.1038/s41582-021-00552-2 NLM Lemprière S. A brain implant decodes speech. Nat Rev Neurol. 2021 Sep;17(9):525. doi: 10.1038/s41582-021-00552-2. PMID: 34373632. Copy Download .nbib Format: NLM AMA APA MLA NLM
Gene therapy effective in model of infantile parkinsonism. Gene therapy effective in model of infantile parkinsonism. Nature reviews. Neurology Lemprière S. PMID: 34083766 Nat Rev Neurol. 2021 Jul;17(7):394. doi: 10.1038/s41582-021-00522-8. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Lemprière S. Gene therapy effective in model of infantile parkinsonism. Nat Rev Neurol. 2021;17(7):394doi: 10.1038/s41582-021-00522-8. APA Lemprière, S. (2021). Gene therapy effective in model of infantile parkinsonism. Nature reviews. Neurology, 17(7), 394. https://doi.org/10.1038/s41582-021-00522-8 MLA Lemprière, Sarah. "Gene therapy effective in model of infantile parkinsonism." Nature reviews. Neurology vol. 17,7 (2021): 394. doi: https://doi.org/10.1038/s41582-021-00522-8 NLM Lemprière S. Gene therapy effective in model of infantile parkinsonism. Nat Rev Neurol. 2021 Jul;17(7):394. doi: 10.1038/s41582-021-00522-8. PMID: 34083766. Copy Download .nbib Format: NLM AMA APA MLA NLM
NLRP3 inflammasome activity as biomarker for primary progressive multiple sclerosis. NLRP3 inflammasome activity as biomarker for primary progressive multiple sclerosis. Nature reviews. Neurology Lemprière S. PMID: 32367013 Nat Rev Neurol. 2020 Jul;16(7):350. doi: 10.1038/s41582-020-0366-y. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Lemprière S. NLRP3 inflammasome activity as biomarker for primary progressive multiple sclerosis. Nat Rev Neurol. 2020;16(7):350doi: 10.1038/s41582-020-0366-y. APA Lemprière, S. (2020). NLRP3 inflammasome activity as biomarker for primary progressive multiple sclerosis. Nature reviews. Neurology, 16(7), 350. https://doi.org/10.1038/s41582-020-0366-y MLA Lemprière, Sarah. "NLRP3 inflammasome activity as biomarker for primary progressive multiple sclerosis." Nature reviews. Neurology vol. 16,7 (2020): 350. doi: https://doi.org/10.1038/s41582-020-0366-y NLM Lemprière S. NLRP3 inflammasome activity as biomarker for primary progressive multiple sclerosis. Nat Rev Neurol. 2020 Jul;16(7):350. doi: 10.1038/s41582-020-0366-y. PMID: 32367013. Copy Download .nbib Format: NLM AMA APA MLA NLM
SARS-CoV-2 and the brain to be studied long-term. SARS-CoV-2 and the brain to be studied long-term. Nature reviews. Neurology Lemprière S. PMID: 32855543 Nat Rev Neurol. 2020 Oct;16(10):522. doi: 10.1038/s41582-020-0405-8. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Lemprière S. SARS-CoV-2 and the brain to be studied long-term. Nat Rev Neurol. 2020;16(10):522doi: 10.1038/s41582-020-0405-8. APA Lemprière, S. (2020). SARS-CoV-2 and the brain to be studied long-term. Nature reviews. Neurology, 16(10), 522. https://doi.org/10.1038/s41582-020-0405-8 MLA Lemprière, Sarah. "SARS-CoV-2 and the brain to be studied long-term." Nature reviews. Neurology vol. 16,10 (2020): 522. doi: https://doi.org/10.1038/s41582-020-0405-8 NLM Lemprière S. SARS-CoV-2 and the brain to be studied long-term. Nat Rev Neurol. 2020 Oct;16(10):522. doi: 10.1038/s41582-020-0405-8. PMID: 32855543; PMCID: PMC7450676. Copy Download .nbib Format: NLM AMA APA MLA NLM
